• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: ICU Medical, GE HealthCare to battle over Medtronic units

Report: ICU Medical, GE HealthCare to battle over Medtronic units

March 29, 2023 By Sean Whooley

ICU Medical GE HealthCare Medtronic logosReuters reported today that ICU Medical (Nasdaq:ICUI) and GE HealthCare (Nasdaq:GEHC) are pursuing two business units Medtronic (NYSE:MDT) aims to sell off.

The outlet cites sources familiar with the situation, saying the companies are looking at Medtronic’s patient monitoring and respiratory interventions businesses. According to Reuters, Medtronic values these businesses between $8 billion and $9 billion.

In October, Medtronic announced its intention to pursue a separation of the company’s Patient Monitoring and Respiratory Interventions businesses. In spinning those businesses off, the company aims to create value for itself and shareholders, CEO Geoff Martha said.

Reports surfaced near the end of last year that GE HealthCare expressed interest in both units in Medtronic’s Medical Surgical portfolio. Those reports also claimed Siemens Healthineers planned to pursue the units, too. Now, Reuters says ICU Medical teamed up with a private equity firm to join the chase. The outlet says ICU Medical submitted an offer for the assets in partnership with Linden Capital Partners. Its sources claim the bid put ICU Medical through to the second round of the auction process.

GE HealthCare enlisted Carlyle Group and Clayton, Dubilier & Rice, Reuters said. They’ve been pursuing rival offers separately, the report said. According to Reuters, GE HealthCare is through to the second round of bidding, too.

Reuters said Medtronic plans to take offers for these two units while it moves to spin the businesses off. Should the coming offers fail to meet Medtronic’s valuations, the company intends to move forward with spinoffs, the report said.

A Medtronic spokesperson told Reuters that the company plans to provide additional detials “in due course.” The remaining involved parties declined to comment to the outlet, while Linden did not respond to Reuters’ requests.

Medtronic’s portfolio changes could continue

The medtech giant has taken on something of a new look over the past several years.

When it announced plans to spinoff the two businesses, Medtronic projected a completed separation in the next 12 to 18 months. The deal needs to meet closing conditions once the company finds a buyer. That includes final approval from the Medtronic board of directors, receipt of tax opinions and other regulatory approvals.

The company hinted at interest in business spinoffs more than a year ago. At the time, analysts suggested that its diabetes and spine businesses seemed the most likely spinoff options.

On the company’s November 2021 second-quarter earnings call, Martha said Medtronic had no current plans to spin off the diabetes business specifically. However, he admitted that the company spent “a lot more time” looking at portfolios and capital allocation to “make sure we’re the right owner.”

In August 2022, Martha said during the company’s first-quarter earnings call that there would be more portfolio management, including potential tuck-in acquisitions and business divestitures.

Medtronic in May announced its intent to form a new medical device company for kidney care. Medtronic and DaVita will co-own the kidney care company. Each hold equal equity stakes. An independent management team leads the company under the terms of the agreement.

Not just business unit shifts at the medtech giant

In addition to the talk of business sales and spinoffs, Medtronic has been in the news a lot recently.

Here are a few recent reports on increasing activity at the company:

  • Earlier this month, the company offered early retirements as layoffs across the industry continue to pile up. Company officials have said there are “significant expense reductions” underway at the medtech giant
  • Regulatory filings shed light on new details surrounding the company’s kidney care venture with DaVita. That includes a new name.
  • In the midst of some uncertainty, the company received some good news in Europe. Its Affera ablation system for mapping and ablating atrial arrhythmias — including AFib — received CE mark.
  • Medtronic updated its website to indicate a change in its business operating units. A promotion indicated the combination of its surgical robotics and surgical innovations units.
  • A day after MassDevice reported this change, Medtronic confirmed the consolidation. It took effect on Feb. 1.
  • The company also partnered with Nvidia to enable an AI Access platform. This move aims to boost the GI Genius intelligent endoscopy module’s capabilities.
  • Its Medtronic Global Holdings S.C.A subsidiary priced an offering of senior notes worth $2 billion. The company wants to strengthen its resilience against the present macroeconomic headwinds.

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Patient Monitoring, Respiratory, Wall Street Beat Tagged With: GE Healthcare, ICU Medical, Medtronic

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy